Total net product revenues for the fourth quarter of 2014 were $13 million, compared to $238 million for the fourth quarter of 2013. GAAP net loss for the fourth quarter of 2014 was $288 million, or a loss of $4.51 per diluted share, compared to net ... World Energy Source, 1 day ago
SALIX PHARMACEUTICALS : Reports 4Q2014 and FY2014 Results - 4 Traders, 1 day ago
Challenges of Correlating pH Change with Relief of Clinical Symptoms in Gastro Esophageal Reflux Disease: A Phase III, Randomized Study of Zegerid versus Losec
by Dave Walker, Richard Ng Kwet Shing, Deborah Jones, Hans-Jurgen Gruss, Jarosław Reguła Background Zegerid (on demand immediate-release omeprazole and sodium bicarbonate combination therapy) has demonstrated earlier absorption and more rapid pH ...Plosone.org, 1 week ago
The present invention relates to a method for forming a pharmaceutical product, such as a dissolvable film dosage form, onto a surface. Particularly, the present invention relates to a method of forming a pharmaceutical product directly onto the ...PharmCast, 1 month ago
FDA MedWatch - December 2014 Safety Labeling Changes posting includes 72 products with changes to Prescribing Information
The MedWatch December 2014 Safety Labeling Changes posting includes 72 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and PATIENT PACKAGE INSERT. The ...Food Consumer, 1 month ago
on your WebpageAdd Widget >Get your members hooked!